During the past decade, Lääkärikeskus Gyneko conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lääkärikeskus Gyneko" are "Endometriosis" (2 trials), "Hot Flashes" (2 trials), "Leiomyoma" (1 trials), "Safety" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "Lääkärikeskus Gyneko" in a lesser frequency.

Most popular intervention types in "Lääkärikeskus Gyneko" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Elinzanetant (BAY3427080)" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "BAY1128688" (1 trials) and "BAY1817080" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lääkärikeskus Gyneko" are 7 trials for "Female" genders.

Currently, there are NaN active trials in "Lääkärikeskus Gyneko". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Lääkärikeskus Gyneko, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lääkärikeskus Gyneko, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".